These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1235 related articles for article (PubMed ID: 9731705)

  • 21. Inhibition of the 1,25-dihydroxyvitamin D3-induced increase in vitamin D receptor (VDR) levels and binding of VDR-retinoid X receptor (RXR) to a direct repeat (DR)-3 type response element by an RXR-specific ligand in human keratinocyte cultures.
    Jensen TJ; Henriksen LO; Sølvsten H; Kragballe K
    Biochem Pharmacol; 1998 Mar; 55(6):767-73. PubMed ID: 9586948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
    Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
    Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
    Tagami T; Lutz WH; Kumar R; Jameson JL
    Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3.
    Zou A; Elgort MG; Allegretto EA
    J Biol Chem; 1997 Jul; 272(30):19027-34. PubMed ID: 9228086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene.
    MacDonald PN; Dowd DR; Nakajima S; Galligan MA; Reeder MC; Haussler CA; Ozato K; Haussler MR
    Mol Cell Biol; 1993 Sep; 13(9):5907-17. PubMed ID: 8395017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
    Matkovits T; Christakos S
    Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of 1,25-dihydroxyvitamin D3 receptor-mediated enhancement of osteocalcin gene transcription: effects of perturbing phosphorylation pathways by okadaic acid and staurosporine.
    Desai RK; van Wijnen AJ; Stein JL; Stein GS; Lian JB
    Endocrinology; 1995 Dec; 136(12):5685-93. PubMed ID: 7588324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
    Peng L; Malloy PJ; Feldman D
    Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
    Russell J; Ashok S; Koszewski NJ
    J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of 1 alpha,25-dihydroxyvitamin D3 response elements in the human transforming growth factor beta 2 gene.
    Wu Y; Craig TA; Lutz WH; Kumar R
    Biochemistry; 1999 Mar; 38(9):2654-60. PubMed ID: 10052935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic analysis of the response of the rat calbindin-D 9k gene to vitamin D.
    Colnot S; Ovejero C; Romagnolo B; Porteu A; Lacourte P; Thomasset M; Perret C
    Endocrinology; 2000 Jul; 141(7):2301-8. PubMed ID: 10875229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two basic amino acids C-terminal of the proximal box specify functional binding of the vitamin D receptor to its rat osteocalcin deoxyribonucleic acid-responsive element.
    Hsieh JC; Whitfield GK; Jurutka PW; Haussler CA; Thatcher ML; Thompson PD; Dang HT; Galligan MA; Oza AK; Haussler MR
    Endocrinology; 2003 Nov; 144(11):5065-80. PubMed ID: 12960019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A central dinucleotide within vitamin D response elements modulates DNA binding and transactivation by the vitamin D receptor in cellular response to natural and synthetic ligands.
    van den Bemd GJ; Jhamai M; Staal A; van Wijnen AJ; Lian JB; Stein GS; Pols HA; van Leeuwen JP
    J Biol Chem; 2002 Apr; 277(17):14539-46. PubMed ID: 11834737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M; Steinmeyer A; Carlberg C
    Chem Biol; 2000 Nov; 7(11):885-94. PubMed ID: 11094341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic actions of 1,25-dihydroxyvitamin D3.
    Whitfield GK; Hsieh JC; Jurutka PW; Selznick SH; Haussler CA; MacDonald PN; Haussler MR
    J Nutr; 1995 Jun; 125(6 Suppl):1690S-1694S. PubMed ID: 7782928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
    Harant H; Spinner D; Reddy GS; Lindley IJ
    J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
    Sørensen S; Sølvsten H; Politi Y; Kragballe K
    Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions.
    Thompson PD; Jurutka PW; Haussler CA; Whitfield GK; Haussler MR
    J Biol Chem; 1998 Apr; 273(14):8483-91. PubMed ID: 9525962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.